Navigation Links
Beardsworth Continues to Strengthen Oncology Operations
Date:5/4/2011

FLEMINGTON, N.J., May 4, 2011 /PRNewswire/ -- Beardsworth announces the promotion of Evette Riegel, RN, to Senior Director, Clinical Operations and Project Management and the addition of Saishree Ramalingam, MS, MPhil as Senior Project Manager.  

(Photo:  http://photos.prnewswire.com/prnh/20110504/NY95605 )

In her new role, Ms. Riegel will lead Beardsworth's expanded focus in oncology clinical operations and execution of all clinical programs.

"Evette's expertise and insight provide an added dimension that strengthens our client services and capabilities across our global OncologyOne(SM) and therapeutic vaccine initiatives.  Her global trial experience and extensive therapeutic knowledge combined with her personal insight as a critical care nurse, give her a unique perspective from which to lead our patient-centric, project management teams," said Michael O'Brien, President & CEO.

Ms. Riegel joined Beardsworth in 2006 as a Senior Project Manager and became Director, Clinical Operations in 2008 with a leading role in the integration of Beardsworth's global services and oncology operations. Previously, Ms. Riegel worked at Quintiles as a global project manager as well as Discovery Laboratories, ViroPharma, and Wyeth.

Saishree Ramalingam, MS, MPhil joins Beardsworth as a Senior Project Manager responsible for leading the company's oncology trials. An experienced research clinician, Ms. Ramalingam has over 13 years experience across multiple therapeutic areas and global projects with a special focus in oncology and vaccines.

Prior to Beardsworth, Ms. Ramalingam held project manager positions at Celgene, Pfizer, GSK/Reliant, Merck, as well as PharmaNet, Applied Clinical Intelligence, and PRA International. She received her master of science at the University of Akron and a master of philosophy from Avinashilingam Deemed Uni
'/>"/>

SOURCE Beardsworth
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Alison Martin, MD and Robert W. Malone, MD Join Beardsworth
2. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
3. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
4. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
5. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
6. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
7. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
8. Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
9. ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results
10. ACORN CRO Continues Growth in Strong Third Quarter
11. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO ... Joseph as Chief Legal Officer.  Mr. Joseph brings ... and has worked in both public and private companies, ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) "Don ... general counsel and senior executive and his knowledge and ...
(Date:6/17/2013)... 2013 zuChem Inc., a leading ... nutrition, announced today that the United States Patent ... - US 8,367,346 entitled “Methods for Production of ... for producing D-Mannitol." These two patents expand zuChem's ... food sweetener products from abundant, renewable feedstocks. ...
(Date:6/17/2013)... NY (PRWEB) June 17, 2013 With the ... the launch of the Chief Medical Officer Summit for Emerging ... will take place in San Francisco on November 4-5, ... For the first time, West Coast Chief Medical Officers at ... Dr. Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) will hold ... event on July 19-21, 2013. The Tri-State Trek is a three-day, ... to Greenwich, CT with the mission to ... disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... passes through 46 communities and includes 12 rest stops, ...
Breaking Biology Technology:KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4zuChem Receives Two Polyol Patents 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3
... 3, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer today announced the presentation of clinical ... platinum-resistant ovarian cancer patients.   The data were presented ... A. Matulonis, medical director of gynecologic oncology at Dana-Farber ...
... 2011 Asmacure Ltee, a clinical-stage biopharmaceutical ... for the treatment of asthma and other inflammatory diseases, ... chief executive officer.  With a solid foundation established at ... progresses its lead compound, a potential new treatment for ...
... KONG, June 3, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ... plan to release financial results for the fourth quarter and ... 2011, after market close in the US.   ... ET on Monday, June 13, 2011 to discuss its financial ...
Cached Biology Technology:EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 2EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 3EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 4Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 2Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 3China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results 2
(Date:6/14/2013)... World War II soldiers, "The White Cliffs of Dover" ... times. To geographers, the white cliffs mark the point ... scientists, the white cliffs are towering structures made of ... alga known as Emiliania huxleyi . "Ehux" is ... Even though the process by which the alga,s "armor" ...
(Date:6/14/2013)... OttawaJune 14, 2013Here,s a good reason to pay ... has published a paper from Ottawa researchers today, ... in the fight against cancer. The technique predicts ... cancer-killing, oncolytic viruses to overcome the natural defences ... infection. , "Oncolytic viruses are special in ...
(Date:6/13/2013)... The World Cultural Council is proud to announce that ... presentations, with its 30th Award Ceremony on Wednesday, 2nd ... and the Programme will be available shortly. , ... criteria for the Science Award of bringing "true benefit ... a scientific leader of several prestigious organizations, with significant ...
Breaking Biology News(10 mins):Chalking up a marine blooming alga: Genome fills a gap in the tree of life 2Chalking up a marine blooming alga: Genome fills a gap in the tree of life 3Chalking up a marine blooming alga: Genome fills a gap in the tree of life 4Using math to kill cancer cells 22013 World Cultural Council awards 22013 World Cultural Council awards 3
... major new review of scientific knowledge on kava a ... with calming effects has left unsolved the mystery of ... in the United States, Europe, and other Western cultures sometimes ... Chemical Research in Toxicology . Line Olsen and colleagues ...
... release is available in German and Spanish ... in Chile pose a higher threat to its neighbour, Argentina, ... University of Concepcin in Chile and the Helmholtz Centre for ... In particular, 22 non-native species which occur in Chile on ...
... , This release is available in German ... protects them against diseases. The early detection of pathogens and ... work as a protective shield. However, the pathogens that cause ... suppress the natural cell wall reaction in plants. "One particularly ...
Cached Biology News:Chile is more dangerous for Argentina than vice versa 2Chile is more dangerous for Argentina than vice versa 3TUM researchers discover a new switch in resistance to plant diseases 2
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
... agent and DNA-topoisomersae II inhibitor (IC50 = 59.2 ... C 29 H 32 O 13 ... Store at: RT ... Soluble to 100 mM ...
NAP-2 (5C7)...
golgi reassembly stacking protein 2, 55kDa...
Biology Products: